Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2009 08:00 ET | Source: Bioheart, Inc.

Bioheart to Present At the Cell & Gene Therapy Forum in Washington, D.C.

SUNRISE, Fla., Jan. 22, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure...
January 20, 2009 21:32 ET | Source: Bioheart, Inc.

Bioheart, Inc. Elects Dr. Karl Groth to Its Board of Directors and Appoints Peggy Farley to Chairman of the Audit Committee

SUNRISE, Fla., Jan. 20, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced that it has elected Dr. Karl Groth, a co-founder of the Ascent Medical Technology Fund, to its Board of...
January 20, 2009 16:35 ET | Source: Bioheart, Inc.

Bioheart, Inc. Reports Receipt of Notification From NASDAQ Regarding Non-Compliance With Continued Listing Requirements

SUNRISE, Fla., Jan. 20, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) today announced that it received a letter from the Nasdaq Stock Market on January 14, 2009 advising that, the Company does...
January 14, 2009 10:54 ET | Source: Bioheart, Inc.

Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients

SUNRISE, Fla., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has received a purchase order for a TGI 1200 System from Philadelphia BioMed Product Development...
January 14, 2009 10:35 ET | Source: Bioheart, Inc.

Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients

SUNRISE, Fla., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has received a purchase order for a TGI 1200 System from Philadelphia BioMed Product Development...
January 13, 2009 10:52 ET | Source: Bioheart, Inc.

Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure

SUNRISE, Fla., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has filed with appropriate agencies in Switzerland for reimbursement approval for its MyoCell(r)...
January 13, 2009 10:42 ET | Source: Bioheart, Inc.

Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure

SUNRISE, Fla., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has filed with appropriate agencies in Switzerland for reimbursement approval for its MyoCell(r)...
January 12, 2009 23:52 ET | Source: Bioheart, Inc.

Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure

Four Years of Sponsored Animal Studies At Cleveland Clinic and the University of Florida Have Demonstrated That Second-generation Cell Therapy, MyoCell(r) SDF-1, Provides Double the Level of...
January 12, 2009 10:07 ET | Source: Bioheart, Inc.

Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure

SUNRISE, Fla., Jan. 12, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today that it plans to conduct clinical trials for its second-generation MyoCell SDF-1 myogenic cell composition...
January 09, 2009 13:56 ET | Source: Bioheart, Inc.

Bioheart Collaborating Researchers to Present At the Fifth International Conference on Cell Therapy for Cardiovascular Disease in New York, January 14-16, 2009

SUNRISE, Fla., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company developing core technologies aimed at serving the heart failure patient population, announced today that eight...